Safety of "Ticagrelor+ Warfarin"in Comparison With "Clopidogrel+Aspirin+Warfarin"
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02206815|
Recruitment Status : Unknown
Verified May 2016 by Genshan Ma, Southeast University, China.
Recruitment status was: Recruiting
First Posted : August 1, 2014
Last Update Posted : May 17, 2016
Information provided by (Responsible Party):
Genshan Ma, Southeast University, China
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||February 2018|
|Estimated Study Completion Date :||June 2018|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Lu W, Chen L, Wang Y, Yao Y, Fu C, Zuo P, Ma G. Rationale and design of MANJUSRI trial: a randomized, open-label, active-controlled multicenter study to evaluate the safety of combined therapy with ticagrelor and warfarin in AF subjects after PCI-eS. Contemp Clin Trials. 2015 Jan;40:166-71. doi: 10.1016/j.cct.2014.12.002. Epub 2014 Dec 13.